Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

05-23-0101 Angiotensin II, Human - CAS 4474-91-3 - Calbiochem

Plays an important role in the regulation of blood pressure.

Angiotensin II, Human - CAS 4474-91-3 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: DRVYIHPF

Primary Target: adenylate cyclase activity
05-23-0101
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
4474-91-3C₅₀H₇₁N₁₃O₁₂

Products

Numero di catalogoConfezionamento Qtà/conf
05-23-0101-1MG Fiala di plastica 1 mg
05-23-0101-25MG Bottiglia di vetro 25 mg
05-23-0101-5MG Fiala di plastica 5 mg
Description
OverviewPlays an important role in the regulation of blood pressure. Stimulates the release of aldosterone from the adrenal gland. Inhibits adenylate cyclase activity in spontaneously hypertensive rats. Has strong vasoconstrictive effects. Increases the entry of Ca2+ in heart muscle via voltage-sensitive channels and activates myosin light chain kinase. Also elicits an increase in voltage-dependent delayed rectifier K+ current in neurons. Activates JAK2 in smooth muscle cells. Activates p125FAK and a cytosolic 115-120 kDa calcium-dependent tyrosine kinase in rat epithelial cells. Also activates p60c-src as well as ERK1/2, JNK, and p38 MAP Kinase in vascular smooth muscle cells.
Catalogue Number05-23-0101
Brand Family Calbiochem®
SynonymsDRVYIHPF
References
ReferencesZhu, M., et al. 2000. J. Neurophysiol. 84, 2494.
Natarajan, R., et al. 1999. Hypertension 33, 378.
Mazzolai, L., et al. 1998. Hypertension 31, 1324.
Earp, H.S., et al. 1995. J. Biol. Chem. 270, 28440.
Ishida, M., et al. 1995. Circ. Res. 77, 1053.
Vyas, S.J., and Jackson, E.K. 1995. J. Pharmacol. Exp. Ther. 273, 768.
Product Information
CAS number4474-91-3
ATP CompetitiveN
FormWhite to off-white solid
Hill FormulaC₅₀H₇₁N₁₃O₁₂
Chemical formulaC₅₀H₇₁N₁₃O₁₂
Hygroscopic Hygroscopic
ReversibleN
Sold on the basis of peptide contentY
Quality LevelMQ100
Applications
Biological Information
Primary Targetadenylate cyclase activity
Purity≥98% by HPLC
Physicochemical Information
Cell permeableN
Peptide ContentY
Peptide SequenceH-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSBW2165000
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Standard Handling
Storage -20°C
Hygroscopic Hygroscopic
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 week at 4°C or for up to 1 month at -20°C.
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
05-23-0101-1MG 04055977206906
05-23-0101-25MG 04055977206913
05-23-0101-5MG 04055977206920

Documentation

Angiotensin II, Human - CAS 4474-91-3 - Calbiochem MSDS

Titolo

Scheda di sicurezza (MSDS) 

Angiotensin II, Human - CAS 4474-91-3 - Calbiochem Certificati d'Analisi

TitoloNumero di lotto
05-23-0101

Riferimenti bibliografici

Panoramica delle referenze
Zhu, M., et al. 2000. J. Neurophysiol. 84, 2494.
Natarajan, R., et al. 1999. Hypertension 33, 378.
Mazzolai, L., et al. 1998. Hypertension 31, 1324.
Earp, H.S., et al. 1995. J. Biol. Chem. 270, 28440.
Ishida, M., et al. 1995. Circ. Res. 77, 1053.
Vyas, S.J., and Jackson, E.K. 1995. J. Pharmacol. Exp. Ther. 273, 768.
Scheda tecnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision12-May-2008 JSW
SynonymsDRVYIHPF
DescriptionFunctions in blood pressure maintenance. Stimulates the release of aldosterone from the adrenal gland. Has strong vasoconstrictive effects. Increases the entry of Ca2+ in heart muscle via voltage-sensitive channels and activates myosin light chain kinase. Activates JAK2 in smooth muscle cells. Activates p125FAK and a cytosolic 115-120 kDa calcium-dependent tyrosine kinase in rat epithelial cells. Also activates pp60c-src in vascular smooth muscle cells. Inhibits adenylate cyclase activity in spontaneously hypertensive rats.
FormWhite to off-white solid
CAS number4474-91-3
RTECSBW2165000
Chemical formulaC₅₀H₇₁N₁₃O₁₂
Peptide SequenceH-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
Purity≥98% by HPLC
Solubility5% acetic acid (1 mg/ml) or H₂O (1 mg/ml)
Storage -20°C
Hygroscopic
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 week at 4°C or for up to 1 month at -20°C.
Toxicity Standard Handling
Merck USA index14 651
ReferencesZhu, M., et al. 2000. J. Neurophysiol. 84, 2494.
Natarajan, R., et al. 1999. Hypertension 33, 378.
Mazzolai, L., et al. 1998. Hypertension 31, 1324.
Earp, H.S., et al. 1995. J. Biol. Chem. 270, 28440.
Ishida, M., et al. 1995. Circ. Res. 77, 1053.
Vyas, S.J., and Jackson, E.K. 1995. J. Pharmacol. Exp. Ther. 273, 768.